Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Appl Oral Sci ; 32: e20240017, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38775598

RESUMO

OBJECTIVE: To compare the effect of submucosal cryotherapy using cold saline to dexamethasone sodium phosphate and diclofenac sodium injections on substance P and interleukin 6 release in experimentally induced pulpal inflammation in rabbits' molar teeth. METHODOLOGY: Fifteen rabbits were randomly classified into 3 groups according to the submucosal injection given: cold saline, dexamethasone sodium phosphate, and diclofenac sodium. A split-mouth design was adopted, the right mandibular molars were experimental, and the left molars served as the control without injections. Intentional pulp exposures were created and left for 6 hours to induce pulpitis. Pulpal tissue was extracted and examined for SP and IL-6 levels using ELISA. Within each group, the level of cytokines released was measured for both control and experimental groups for intragroup comparison to determine the effect of injection. The percentage reduction of each mediator was calculated compared with the control side for intergroup comparison then the correlation between SP and IL-6 levels was analyzed using Spearman's rank order correlation coefficient. Statistical analysis was performed, and the significance level was set at p<0.05. RESULTS: Submucosal cryotherapy, dexamethasone sodium phosphate, and diclofenac sodium significantly reduced SP and IL-6 pulpal release. Submucosal cryotherapy significantly reduced SP more than and IL-6 more than dexamethasone sodium phosphate and diclofenac sodium. Pulpal reduction of SP and IL-6 showed a strong positive significant correlation. CONCLUSIONS: Submucosal cryotherapy reduces the pulpal release of SP and IL-6 and could be tested as an alternative to premedication to potentiate the effect of anesthesia and control postoperative endodontic pain.


Assuntos
Anti-Inflamatórios não Esteroides , Crioterapia , Polpa Dentária , Dexametasona , Diclofenaco , Ensaio de Imunoadsorção Enzimática , Interleucina-6 , Pulpite , Distribuição Aleatória , Substância P , Animais , Coelhos , Pulpite/terapia , Diclofenaco/farmacologia , Dexametasona/farmacologia , Dexametasona/análogos & derivados , Interleucina-6/análise , Crioterapia/métodos , Substância P/análise , Anti-Inflamatórios não Esteroides/farmacologia , Polpa Dentária/efeitos dos fármacos , Fatores de Tempo , Reprodutibilidade dos Testes , Resultado do Tratamento , Masculino , Estatísticas não Paramétricas , Modelos Animais de Doenças , Anti-Inflamatórios/farmacologia , Solução Salina , Valores de Referência
2.
J Control Release ; 369: 746-764, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38599547

RESUMO

Acute respiratory distress syndrome (ARDS) is a critical illness characterized by severe lung inflammation. Improving the delivery efficiency and achieving the controlled release of anti-inflammatory drugs at the lung inflammatory site are major challenges in ARDS therapy. Taking advantage of the increased pulmonary vascular permeability and a slightly acidic-inflammatory microenvironment, pH-responsive mineralized nanoparticles based on dexamethasone sodium phosphate (DSP) and Ca2+ were constructed. By further biomimetic modification with M2 macrophage membranes, hybrid mineralized nanovesicles (MM@LCaP) were designed to possess immunomodulatory ability from the membranes and preserve the pH-sensitivity from core nanoparticles for responsive drug release under acidic inflammatory conditions. Compared with healthy mice, the lung/liver accumulation of MM@LCaP in inflammatory mice was increased by around 5.5 times at 48 h after intravenous injection. MM@LCaP promoted the polarization of anti-inflammatory macrophages, calmed inflammatory cytokines, and exhibited a comprehensive therapeutic outcome. Moreover, MM@LCaP improved the safety profile of glucocorticoids. Taken together, the hybrid mineralized nanovesicles-based drug delivery strategy may offer promising ideas for enhancing the efficacy and reducing the toxicity of clinical drugs.


Assuntos
Anti-Inflamatórios , Dexametasona , Glucocorticoides , Pulmão , Nanopartículas , Síndrome do Desconforto Respiratório , Animais , Glucocorticoides/administração & dosagem , Glucocorticoides/farmacocinética , Glucocorticoides/uso terapêutico , Dexametasona/administração & dosagem , Dexametasona/farmacocinética , Dexametasona/uso terapêutico , Dexametasona/análogos & derivados , Distribuição Tecidual , Nanopartículas/química , Camundongos , Síndrome do Desconforto Respiratório/tratamento farmacológico , Pulmão/metabolismo , Pulmão/efeitos dos fármacos , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/farmacocinética , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Masculino , Liberação Controlada de Fármacos , Pneumonia/tratamento farmacológico , Pneumonia/induzido quimicamente , Células RAW 264.7 , Sistemas de Liberação de Medicamentos , Cálcio/metabolismo , Citocinas/metabolismo
3.
Arch. endocrinol. metab. (Online) ; 64(3): 243-250, May-June 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1131091

RESUMO

ABSTRACT Objective Intrathyroid injection of dexamethasone (IID) was used for decrease the relapse rate of hyperthyroidism in the treatment of Graves' disease (GD), but the mechanism is still unclear. We aimed to explore the effect of IID on T help (Th)1/Th2 cells and their chemokine in patients with GD. Subjects and methods A total of 42 patients with GD who were euthyroidism by methimazole were randomly divided into IID group (n = 20) and control group (n = 22). Thyroid function and associated antibody, Th1/Th2 cells proportion, serum CXCL10 and CCL2 levels, and CXCR3/CCR2 mRNA expression in peripheral blood mononuclear cells before and after 3-month IID treatment were tested by chemiluminescence assay, Flow cytometry, ELISA, and real-time PCR, respectively. Thyroid follicular cells were stimulated by IFN-γ and TNF-α and treated with dexamethasone in vitro. CXCL10 and CCL2 levels in supernatant were determined. Results After 3-month therapy, the proportion of Th2 cells and serum CCL2 levels, as well as TPOAb, TRAb levels and thyroid volume decreased in IID group (p < 0.05). However, the proportion of Th1 and CXCL10 levels had no change in IID group and control (p > 0.05). The CXCR3/CCR2 ratio had no change in both groups (p > 0.05). Conclusion IID therapy could inhibit peripheral Th2 cells via decreasing CCL2 level in peripheral blood, and this result partly explain the effects of IID therapy on prevention of relapse of GD. Arch Endocrinol Metab. 2020;64(3):243-50


Assuntos
Humanos , Masculino , Feminino , Adulto , Dexametasona/análogos & derivados , Doença de Graves/tratamento farmacológico , Células Th2/efeitos dos fármacos , Células Th1/efeitos dos fármacos , Anti-Inflamatórios/administração & dosagem , Recidiva , Resultado do Tratamento , Prevenção Secundária , Pessoa de Meia-Idade
4.
Rev. latinoam. enferm ; 22(6): 1026-1033, 16/12/2014.
Artigo em Inglês | LILACS, BDENF - Enfermagem | ID: lil-732940

RESUMO

OBJECTIVE: to identify the perceptions of professionals working in a facility connected with the Brazilian Unified Health System - SUS in regard to what they know, think and talk about public health policy. METHOD: this exploratory-descriptive study with a qualitative nature was conducted with 28 professionals working in a facility connected with the SUS. Data were collected through interviews with guiding questions and analyzed through the thematic content analysis technique. RESULTS: coded and interpreted data resulted in three thematic axes: The SUS - perfect web that does not work in practice; The recurrent habit of complaining about the SUS; The need to rethink the way of thinking about, acting in and managing the SUS. CONCLUSION: the professionals working for the SUS are aware of the principles and guidelines that govern the Brazilian health system, however, they reproduce a dichotomous and linear model of conception and practice strongly linked to the thinking of society in general. .


OBJETIVO: conhecer a percepção de profissionais que atuam em uma instituição conveniada com o Sistema Único de Saúde sobre o que sabem, pensam e falam dessa política pública de saúde. MÉTODO: trata-se de estudo exploratório-descritivo, de caráter qualitativo, realizado com 28 profissionais que atuam em uma instituição conveniada com o Sistema Único de Saúde. Os dados foram coletados por meio de entrevistas com questões norteadoras e analisados pela técnica de análise de conteúdo temática. RESULTADOS: os dados codificados e interpretados resultaram em três eixos temáticos: Sistema Único de Saúde - teia perfeita que não funciona na prática; o recorrente hábito de reclamar do Sistema Único de Saúde; a necessidade de repensar o modo de pensar, atuar e gerir o Sistema Único de Saúde. CONCLUSÃO: os profissionais que atuam no Sistema Único de Saúde têm conhecimento dos princípios e diretrizes que regem o sistema de saúde nacional, no entanto, reproduzem um modelo de concepção e atuação dicotômico, pontual e linear ainda fortemente vigente no pensar da sociedade em geral. .


OBJETIVO: conocer la percepción de profesionales que actúan en una institución que tiene convenio con el Sistema Único de Salud - SUS sobre lo que saben, piensan y hablan de esta política pública de salud. MÉTODO: se trata de un estudio exploratorio descriptivo, de carácter cualitativo, realizado con 28 profesionales que actúan en una institución que tiene convenio con el SUS. Los datos fueron recolectados por medio de entrevistas con preguntas orientadoras y analizados con la técnica de análisis de contenido temático. RESULTADOS: los datos codificados y interpretados resultaron en tres ejes temáticos: SUS - red perfecta que no funciona en la práctica; el recurrente hábito de reclamar del SUS; y la necesidad de repensar el modo de pensar, actuar y administrar el SUS. CONCLUSIÓN: los profesionales que actúan en el SUS tienen conocimiento de los principios y directrices que gobiernan el sistema de salud nacional, sin embargo, reproducen un modelo de concepción y actuación dicotómico, puntual, linear y además fuertemente vigente en el pensar de la sociedad en general. .


Assuntos
Animais , Masculino , Ratos , Dexametasona/análogos & derivados , Peso Corporal/efeitos dos fármacos , Corticosterona/sangue , Citosol/metabolismo , Citosol/ultraestrutura , Dexametasona/farmacologia , Fígado/metabolismo , Fígado/ultraestrutura , Molibdênio/farmacologia , Ratos Endogâmicos , Receptores de Glucocorticoides/metabolismo , Timo/metabolismo , Timo/ultraestrutura , Trítio
5.
Int. braz. j. urol ; 34(6): 758-764, Nov.-Dec. 2008. graf, tab
Artigo em Inglês | LILACS | ID: lil-505656

RESUMO

PURPOSE: Evaluate the benefits of electromotive drug administration (EMDA) as an alternative technique in patients with chronic overactive bladder in terms of improvement of symptoms, quality of life, and sexuality. MATERIAL AND METHODS: A total of 72 patients with therapy-refractory overactive bladder according to the ICS (International Continence Society) definition, were treated by EMDA. The regimen consisted of three treatment cycles, each with 3 instillations at 2-week intervals. The solution instilled consisted of 100 mL 4 percent lidocaine, 100 mL distilled water, 40 mg dexamethasone, and 2 mL epinephrine. Peri-interventionally, a urine test and close circulatory monitoring were performed. All women underwent urodynamic testing and cystoscopy and kept a voiding diary. A comprehensive history was obtained, a quality of life questionnaire administered, and a gynecologic examination performed before initiation of therapy. The women underwent follow-up at 12 months after the end of therapy. RESULTS: The patients had a mean age of 63 (± 11.2) years. Bladder capacity improved significantly by 109 mL (± 55 mL) in 51 (71 percent) patients (p = 0.021). The number of micturitions/day decreased significantly to 7 (± 2) (p = 0.013). Quality of life was improved in 54 patients (75 percent); p = 0.024) and sexuality in 39 (54 percent); p = 0.020). CONCLUSIONS: The results suggest that EMDA can improve both quality of life and sexuality in patients with therapy-refractory chronic overactive bladder.


Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Eletroquimioterapia , Qualidade de Vida , Comportamento Sexual , Bexiga Urinária Hiperativa/tratamento farmacológico , Dexametasona/administração & dosagem , Dexametasona/análogos & derivados , Epinefrina/administração & dosagem , Lidocaína/administração & dosagem , Resultado do Tratamento , Bexiga Urinária Hiperativa/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA